Oregon Cancer

News and information for cancer services throughout Oregon.

  • Three phases of clinical trials round out a year of research advancements

    Three phases of clinical trials round out a year of research advancements

    Providence Cancer Institute is offering a phase III trial for patients with gynecologic cancers and two early phase trials that will study new medications in treating solid tumors.

    Read Article
  • Fellowship trains next generation of immuno-oncology experts

    Fellowship trains next generation of immuno-oncology experts

    Providence currently accepting applications for an Immuno-Oncology Research Fellowship being offered through Earle A. Chiles Research Institute.

    Read Article
  • Providence immunologist honored at leading cancer conference

    Providence immunologist honored at leading cancer conference

    Bernard A. Fox, Ph.D., leader of the Laboratory of Molecular and Tumor Immunology honored by the Society for Immunotherapy of Cancer for legacy of public service.

    Read Article
  • Learn how integrative medicine can improve quality of life for cancer patients

    Learn how integrative medicine can improve quality of life for cancer patients

    Providence Cancer Institute to hold two virtual events on the benefits of integrative medicine for patients.

    Read Article
  • Providence among few sites worldwide offering new trials for solid tumors and lung cancer

    Providence among few sites worldwide offering new trials for solid tumors and lung cancer

    Providence Cancer Institute one of only a few sites worldwide offering two new clinical trials for solid tumors and lung cancer.

    Read Article
  •  Three new studies are focus of Breast Cancer Awareness Month

    Three new studies are focus of Breast Cancer Awareness Month

    Providence Cancer Institute is currently recruiting participants for three new clinical studies offered for people with HER2-neu negative breast cancer.

    Read Article
  • Providence lung cancer experts to present at oncology summit

    Providence lung cancer experts to present at oncology summit

    Leading lung cancer professionals to gather in November for premier oncology summit.

    Read Article
  • Medical expert shares promising treatments and latest research for gynecologic cancers

    Medical expert shares promising treatments and latest research for gynecologic cancers

    Providence gynecologic oncologist Christopher Darus, M.D. shares the latest research and promising treatments for gynecologic cancers.

    Read Article
  • Understanding lymphoma: The Basics and Beyond with Dr. Natasha Edwin

    Understanding lymphoma: The Basics and Beyond with Dr. Natasha Edwin

    Providence hematology expert offers the most updated information about lymphoma, treatment options and helpful community resources.

    Read Article
  • New trial is first to study targeted therapy combination for treating thyroid cancer

    New trial is first to study targeted therapy combination for treating thyroid cancer

    New investigator-initiated clinical trial available only at Providence Cancer Institute will evaluate the safety and efficacy of targeted therapy combination for treating thyroid cancer.

    Read Article
  • Providence Cancer Institute shares updates on advances in care for melanoma patients

    Providence Cancer Institute shares updates on advances in care for melanoma patients

    Providence Cancer Institute experts share their insights on recent advances in melanoma research and care, and tips on communicating with loved ones in a virtual symposium.

    Read Article
  • Shorter treatment duration with new therapy is focus of rectal cancer trial

    Shorter treatment duration with new therapy is focus of rectal cancer trial

    New Providence-sponsored study may provide new insights into the efficacy of shorter duration radiation and chemotherapy treatment before surgery for people with stage II/III rectal cancer

    Read Article
  • Colorectal cancer undetectable in patients after participating in immunotherapy study

    Colorectal cancer undetectable in patients after participating in immunotherapy study

    Results of a phase II clinical trial shows that adding an immunotherapy pill to standard pre-surgery treatment of colorectal cancer patients doubled the successful outcomes.

    Read Article
  • Multi-indication clinical trials help evaluate new medications for future treatments

    Multi-indication clinical trials help evaluate new medications for future treatments

    Two early phase trials testing the safety and tolerability of new medications may help people with sarcomas, lymphomas and other cancers.

    Read Article
  • Novel immunotherapy for pancreatic cancer employed by Providence researchers featured in New England Journal of Medicine

    Novel immunotherapy for pancreatic cancer employed by Providence researchers featured in New England Journal of Medicine

    Adoptive cell therapy study at Providence Cancer Institute gives hope to woman with metastatic pancreatic cancer. Results may lead to new treatments and longer lives for people with advanced cancers.

    Read Article
  • Providence cancer research highlighted at ESMO20

    Providence cancer research highlighted at ESMO20

    Providence Cancer Institute joins oncology professionals around the world for ESMO Virtual Congress 2020, the annual meeting of the European Society for Medical Oncology, held online from September 14

    Read Article
  • Melanoma study: are two immunotherapies better than one?

    Melanoma study: are two immunotherapies better than one?

    A newly opened Phase 3 study at Providence Cancer Institute hopes to shed new light on the benefits of two immunotherapies, nivolumab and NKTR-214, for patients with advanced melanoma.

    Read Article
  • New research lab will focus on improving treatments for soft tissue sarcoma

    New research lab will focus on improving treatments for soft tissue sarcoma

    Dr. Jianguo Huang to lead the Preclinical Cancer Therapy Laboratory with a focus on bridging sarcoma research and immunotherapy

    Read Article
  • Earle A. Chiles Research Institute scientist awarded K22 to develop new lab

    Earle A. Chiles Research Institute scientist awarded K22 to develop new lab

    Providence researcher awarded National Institutes of Health grant to lead a new lab focusing on the discovery of novel inflammatory pathways in cancer that are targets for therapeutic intervention.

    Read Article
  • Boost cancer prevention and survival through Asian nutritional diet

    Boost cancer prevention and survival through Asian nutritional diet

    Learn about the health benefits of a traditional Asian diet at this free, online education event presented by Providence Cancer Institute and the Asian Health & Service Center.

    Read Article
  • loading
    Loading More...